Costs of adverse drug events high

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2016年 / 1617卷 / 1期
关键词：
D O I：
10.1007/s40278-016-20786-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [1] COSTS OF ADVERSE DRUG EVENTS: SYSTEMATIC REVIEW
    Batel-Marques, F.
    Penedones, A.
    Alves, C.
    Mendes, D.
    VALUE IN HEALTH, 2015, 18 (07) : A517 - A517
  • [2] The Costs of Adverse Drug Events in Community Hospitals
    Hug, Balthasar L.
    Keohane, Carol
    Seger, Diane L.
    Yoon, Catherine
    Bates, David W.
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2012, 38 (03): : 120 - 126
  • [3] The costs of adverse drug events in hospitalized patients
    Bates, DW
    Spell, N
    Cullen, DJ
    Burdick, E
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Leape, LL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04): : 307 - 311
  • [4] Direct and indirect costs of adverse drug events
    Gyllensten, H.
    Hakkarianen, K. M.
    Rehnberg, C.
    Natanaelsson, J.
    Sundell, K. Andersson
    Petzold, M.
    Svensson, S.
    Hagg, S.
    Jonsson, A. K.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2017, 27
  • [5] Counting the Costs of Drug-Related Adverse Events
    T. Jeffrey White
    Annet Arakelian
    Jay P. Rho
    PharmacoEconomics, 1999, 15 : 445 - 458
  • [6] Counting the costs of drug-related adverse events
    White, TJ
    Arakelian, A
    Rho, JP
    PHARMACOECONOMICS, 1999, 15 (05) : 445 - 458
  • [7] How to collect and analyze costs associated with adverse drug events
    Basskin, L
    FORMULARY, 1996, 31 (05) : 399 - 403
  • [8] Comparing Methods for Estimating Direct Costs of Adverse Drug Events
    Gyllensten, Hanna
    Jonsson, Anna K.
    Hakkarainen, Katja M.
    Svensson, Staffan
    Hagg, Staffan
    Rehnberg, Clas
    VALUE IN HEALTH, 2017, 20 (10) : 1299 - 1310
  • [9] Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
    Katsuno, Hayato
    Tachi, Tomoya
    Matsuyama, Takuya
    Sugioka, Mayuko
    Aoyama, Satoshi
    Osawa, Tomohiro
    Noguchi, Yoshihiro
    Yasuda, Masahiro
    Goto, Chitoshi
    Mizui, Takashi
    Teramachi, Hitomi
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] Evaluating the costs of adverse drug events in hospitalized patients: a systematic review
    Maxime Durand
    Christel Castelli
    Clarisse Roux-Marson
    Jean-Marie Kinowski
    Géraldine Leguelinel-Blache
    Health Economics Review, 14
12345